OSE Immunotherapeutics announces collaboration with Microsoft
16 June 2022OSE selected by Microsoft France to join the “Biotech Scaler Program” launched during “Viva Technology”, the European Startup and Tech... View Article
Safety and efficacy results of LIS1, a new induction treatment in organ transplantation by the French biotech XENOTHERA
9 June 2022Results from the clinical trial of LIS1, XENOTHERA’s polyclonal glyco-humanised antibody and induction immunosuppressant in solid organ transplantation, were presented... View Article
Owkin announces multi-year clinical data science strategic collaboration with Bristol Myers Squibb
8 June 2022Owkin announced that it has entered into a multi-year, strategic collaboration with Bristol Myers Squibb to apply Owkin’s Artificial Intelligence... View Article